Post

New research · Urology
Future oncology (London, England) · 17h
Case-controlFuture oncology (London, England) · 2026

Lipid biomarkers of prostate cancer: insights from triglycerides and saturated fatty acid metabolism.

Jia Wei He, Pei Zhen Li
Read paper
UrologyCase-control

Higher triglyceride levels associated with greater odds of prostate cancer

Lipid biomarkers of prostate cancer: insights from triglycerides and saturated fatty acid metabolism.

Jia Wei He et al. · Future oncology (London, England) · 2026
Background

Prostate cancer poses a substantial threat to men's health.

Methods

A multicenter case-control study was executed.

Results

Higher triglycerides linked to higher odds of prostate cancer (odds, not risk)

OR by subgroup · 95% CI
null = 1
Triglycerides
4.23
saturated fatty acid/fatty acid ratio
3.89
continuous Gleason score
2.89
More results

Both indicators were positively correlated with continuous Gleason score (triglyceride: β = 0.710, OR = 2.89, 95% CI: 1.96-4.26, p < 0.001; saturated fatty acid/fatty acid: β = 0.645, OR = 2.57, 95% CI: 1.78-3.71, p < 0.001), and were significantly elevated in prostate cancer tissues compared with adjacent non-cancerous tissues.

“
Conclusion

This study confirms the importance of triglycerides and saturated fatty acid/fatty acid ratio in prostate cancer progression, which could be used for diagnosis and prognosis. Reducing their levels may help prevent prostate cancer.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
71.8%
most urologists never used a standard survey to assess stent symptoms
Cohort Study
SIR 1.67
young bladder cancer survivors have a higher risk of developing second cancers compared to the general population
Cohort Study
98%
98% of patients had no significant rectocele after laparoscopic double sacrocolpopexy.
Cohort Study
OR 0.10
Beyond 4000 J/ml, the odds of reintervention are 90% lower.
Randomized Trial
hazard ratio 0·67
pirarubicin instillation led to a lower risk of recurrence compared to observation
Study
3,216
This many specific enhancers were found in prostate cancer cells, not normal cells.
Study
75%
experts agreed on the recommendations for managing prostate cancer recurrence
Cohort Study
HR 1.87
lower muscle quality means nearly twice the risk of dying from advanced prostate cancer